Eben Tessari Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Eben Tessari is CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 61,563 shares of KNSA, which is worth approximately $1.72 Million. The most recent transaction as insider was on Jun 16, 2025, when has been sold 17,300 shares (Class A Ordinary Share) at a price of $28.28 per share, resulting in proceeds of $489,244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.6K

25.25% 3M change

51.15% 12M change

Total Value Held $1.72 Million

Eben Tessari Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 16 2025	SELL Open market or private sale	$489,244 $28.28 p/Share	17,300 Reduced 21.94%	61,563 Class A Ordinary Share
Jun 16 2025	BUY Exercise of conversion of derivative security	$57,395 $8.83 p/Share	6,500 Added 7.61%	78,863 Class A Ordinary Share
Jun 11 2025	SELL Open market or private sale	$1,374,231 $30.51 p/Share	45,042 Reduced 38.36%	72,363 Class A Ordinary Share
Jun 11 2025	BUY Exercise of conversion of derivative security	$466,635 $10.36 p/Share	45,042 Added 27.73%	117,405 Class A Ordinary Share
Jun 10 2025	SELL Open market or private sale	$472,312 $30.46 p/Share	15,506 Reduced 17.65%	72,363 Class A Ordinary Share
Jun 10 2025	BUY Exercise of conversion of derivative security	$160,642 $10.36 p/Share	15,506 Added 15.0%	87,869 Class A Ordinary Share
Jun 09 2025	SELL Open market or private sale	$313,491 $30.38 p/Share	10,319 Reduced 12.48%	72,363 Class A Ordinary Share
Jun 09 2025	BUY Exercise of conversion of derivative security	$106,904 $10.36 p/Share	10,319 Added 11.1%	82,682 Class A Ordinary Share
May 19 2025	SELL Open market or private sale	$316,920 $26.41 p/Share	12,000 Reduced 14.22%	72,363 Class A Ordinary Share
May 19 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 7.66%	84,363 Class A Ordinary Share
Apr 14 2025	SELL Open market or private sale	$245,640 $20.47 p/Share	12,000 Reduced 13.43%	77,363 Class A Ordinary Share
Apr 14 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 7.26%	89,363 Class A Ordinary Share
Apr 07 2025	SELL Payment of exercise price or tax liability	$16,244 $20.28 p/Share	801 Reduced 0.96%	82,363 Class A Ordinary Share
Apr 07 2025	BUY Exercise of conversion of derivative security	-	2,726 Added 3.17%	83,164 Class A Ordinary Share
Apr 01 2025	SELL Payment of exercise price or tax liability	$22,510 $21.77 p/Share	1,034 Reduced 1.27%	80,438 Class A Ordinary Share
Apr 01 2025	BUY Exercise of conversion of derivative security	-	3,519 Added 4.14%	81,472 Class A Ordinary Share
Mar 16 2025	SELL Payment of exercise price or tax liability	$13,045 $22.61 p/Share	577 Reduced 0.73%	77,953 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	1,964 Added 2.44%	78,530 Class A Ordinary Share
Mar 10 2025	SELL Open market or private sale	$261,333 $21.06 p/Share	12,409 Reduced 13.95%	76,566 Class A Ordinary Share
Mar 10 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 7.29%	88,975 Class A Ordinary Share
Feb 10 2025	SELL Open market or private sale	$273,980 $19.57 p/Share	14,000 Reduced 14.59%	81,975 Class A Ordinary Share
Feb 10 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 6.8%	95,975 Class A Ordinary Share
Jan 13 2025	SELL Open market or private sale	$260,540 $18.61 p/Share	14,000 Reduced 13.6%	88,975 Class A Ordinary Share
Jan 13 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 6.37%	102,975 Class A Ordinary Share
Dec 16 2024	SELL Open market or private sale	$470,467 $20.44 p/Share	23,017 Reduced 19.34%	95,975 Class A Ordinary Share

Eben Tessari

CHIEF OPERATING OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account